放射性医薬品前臨床CROの世界市場：成長、将来展望、競合分析、2024～2032年

放射性医薬品前臨床CRO（医薬品開発業務受託機関）市場は、放射性医薬品分野における前臨床研究の推進に不可欠なダイナミックなセクターです。放射性医薬品前臨床CRO市場は、PETトレーサー研究の進展、腫瘍学および神経学研究の需要拡大、CRO間の戦略的提携などを背景に、2024～2032年の予測期間中にCAGR 8.5％で成長すると予測されています。治療用放射性医薬品開発における課題は、シームレスなトランスレーショナルリサーチの重要性を浮き彫りにしています。放射性医薬品タイプと治療分野によるセグメンテーションは、治療用途へのシフトと神経学研究の重要性の高まりを強調し、市場力学の微妙な理解を提供します。地理的な区分では、世界の動向と、前臨床放射性医薬品研究の将来形成におけるアジア太平洋の極めて重要な役割を強調しています。

PETトレーサー研究の進展

PET（陽電子放射断層撮影）トレーサー研究の進展により、放射性医薬品前臨床CRO市場は大きく活性化しています。その証拠に、CovanceやCharles River Laboratoriesなどの大手CROは、さまざまな前臨床試験用の新規PETトレーサーの開発に積極的に貢献しています。PETトレーサーが提供する感度と精度の向上により、前臨床試験においてより正確なイメージングと分析が可能になり、疾患メカニズムと治療反応のより深い理解が促進されます。

オンコロジー研究の需要拡大

オンコロジー研究に対する需要の高まりは、放射性医薬品前臨床CRO市場の主要な促進要因となっています。Jubilant Biosys社やSelcia社などのCROは、がん領域の前臨床研究が急増していることを示す証拠データもあります。がん治療領域は2024年に大きな収益を上げるだけでなく、2024～2032年までの予測期間中に最も高いCAGRを示します。このことは、がん研究の進展を支援し、診断および治療目的の革新的な放射性医薬品の研究開発に貢献するCROの極めて重要な役割を裏付けています。

神経学研究への関心の高まり

神経学研究への関心の高まりは、放射性医薬品前臨床CRO市場のもう一つの促進要因として浮上しています。証拠に基づく洞察によると、PharmaronやWuXi AppTecなどのCROは神経学に焦点を当てた前臨床研究に積極的に取り組んでいます。イメージング技術の進歩や神経変性疾患に対する理解の深まりにより、神経領域の治療領域は予測期間中に大きな収益と高い予想CAGRを示します。このことは、神経科学研究の支援におけるCROの重要な役割を浮き彫りにし、神経疾患の診断と治療における画期的な進歩への道を開くものです。

治療用放射性医薬品開発における課題

前向きな勢いにもかかわらず、治療用放射性医薬品開発における課題が顕著な足かせとなっています。前臨床試験で得られた知見を臨床的に実行可能な治療用放射性医薬品に転換する際に、時折ハードルがあることを示す証拠があります。Eurofins DiscoverXやNuvisanを含むCROは、前臨床から臨床開発へのシームレスな移行の必要性を強調し、これらの課題に積極的に取り組んでいます。この阻害要因は、障壁を克服し、前臨床で検証された放射性医薬品の臨床への移行を促進するための共同努力と強固なトランスレーショナルリサーチの枠組みの重要性を強調しています。

放射性医薬品タイプ別市場分析：PETトレーサーが市場を独占

放射性医薬品タイプ別に市場セグメンテーションを行うと、PETトレーサー、SPECT（単光子放出コンピュータ断層撮影）トレーサー、治療用放射性医薬品のダイナミックな動向が明らかになります。2024年には、PETトレーサーが市場を席巻し、最も高い収益を上げ、市場全体のシェアに大きく貢献しています。しかし、2024～2032年までの予測期間中に予想されるCAGRが最も高いのは治療用放射性医薬品です。このセグメンテーションは、治療用途への顕著なシフトを伴う放射性医薬品前臨床研究の進化を裏付けるものです。

治療分野別市場分析：がん領域が市場を独占

治療領域別の市場内訳では、前臨床研究における腫瘍学、循環器学、神経学、その他の領域の優位性が強調されています。2024年には、がん関連研究への注目が高まっていることを背景に、腫瘍学が最も高い売上を獲得します。同時に、神経学は2024～2032年までの予測期間中に期待されるCAGRが最も高く、神経疾患の理解と対処に重点が置かれるようになっていることを反映しています。このセグメンテーションは、複数の治療領域における前臨床試験での放射性医薬品の多様な用途に関する洞察を提供します。

北米は引き続き世界のリーダー

放射性医薬品前臨床CRO市場の地理的セグメンテーションにより、世界の動向と地域差が明らかになった。2024年には、北米がCovanceやCharles River LaboratoriesのようなCROが重要な役割を果たし、収益と市場シェアの両面でリードします。しかし、新興経済諸国における研究開発への注力の高まりや、世界製薬企業との共同研究の増加といった要因によって、予測期間中はアジア太平洋地域が最も高いCAGRを示すと予想されます。この変化は、市場の世界な性質と、多様な研究環境に対応するための地域別戦略の必要性を浮き彫りにしています。

予測期間中に激化する市場競合

競合情勢の特徴は、戦略的提携と全体的な市場展望です。2024年時点では、Covance、Charles River Laboratories、PharmaronなどのCROが市場を独占しているが、これは包括的な能力と前臨床研究への多大な貢献を反映しています。戦略としては、製薬企業との共同事業、サービス提供の拡大、最先端技術への投資などが挙げられます。2024～2032年にかけて、これらのCROは戦略的イニシアチブを継続し、新たな市場力学に適応し、世界規模での放射性医薬品研究の進展に貢献すると予想されます。

本レポートでお答えする主な質問

放射性医薬品前臨床CRO市場の成長に影響を与える主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントおよび地域に関する主要な投資ポケットは何か？

2032年までの推定推計・市場予測

予測期間中に最も速いCAGRを占めるセグメントは？

市場シェアの大きいセグメントとその理由は？

中低所得国は放射性医薬品前臨床CRO市場に投資しているか？

放射性医薬品前臨床CRO市場で最大の地域市場はどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

放射性医薬品前臨床CRO市場の成長を促進する主要動向は？

世界の放射性医薬品前臨床CRO市場で存在感を高めるための主要な競合企業とその戦略とは？

目次

第1章 序文

• レポート内容
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

第3章 放射性医薬品前臨床CRO市場：競合分析

• 主要ベンダーの市場での位置付け
• ベンダーが採用する戦略
• 主要な産業戦略
• ティア分析：2023年 vs 2031年

第4章 放射性医薬品前臨床CRO市場：マクロ分析と市場力学

• イントロダクション
• 世界の放射性医薬品前臨床CROの市場価値、2021～2031年
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• Porter's ファイブフォースモデル
  • 供給企業の力
  • 買い手の力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治的情勢
  • 経済情勢
  • 技術情勢
  • 法的情勢
  • 社会的情勢

第5章 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2031年
• 市場セグメンテーション
  • 安全性評価
  • 生体分析検査
  • 用量製剤
  • 薬事関連サポート

第6章 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2031年
• 市場セグメンテーション
  • 製薬企業
  • バイオテクノロジー企業
  • 学術調査機関
  • 政府機関

第7章 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2031年
• 市場セグメンテーション
  • PETトレーサー
  • SPECTトレーサー
  • 治療用放射性医薬品

第8章 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2031年
• 市場セグメンテーション
  • 腫瘍学
  • 心臓病学
  • 神経内科
  • その他

第9章 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2031年
• 市場セグメンテーション
  • 中小企業（SME）
  • 大手製薬会社

第10章 北米の放射性医薬品前臨床CRO市場、2022～2032年

• 市場概要
• 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年
• 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年
• 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年
• 放射性医薬品前臨床CRO市場：地域別、2022～2032年
  • 北米
    • 米国
    • カナダ
    • その他の北米

第11章 英国・欧州連合の放射性医薬品前臨床CRO市場、2022～2032年

• 市場概要
• 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年
• 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年
• 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年
• 放射性医薬品前臨床CRO市場：地域別、2022～2032年
  • 英国・欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他の英国・欧州連合

第12章 アジア太平洋の放射性医薬品前臨床CRO市場、2022～2032年

• 市場概要
• 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年
• 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年
• 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年
• 放射性医薬品前臨床CRO市場：地域別、2022～2032年
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋

第13章 ラテンアメリカの放射性医薬品前臨床CRO市場、2022～2032年

• 市場概要
• 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年
• 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年
• 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年
• 放射性医薬品前臨床CRO市場：地域別、2022～2032年
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ

第14章 中東・アフリカの放射性医薬品前臨床CRO市場、2022～2032年

• 市場概要
• 放射性医薬品前臨床CRO市場：サービスタイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：最終用途産業別、2022～2032年
• 放射性医薬品前臨床CRO市場：放射性医薬品タイプ別、2022～2032年
• 放射性医薬品前臨床CRO市場：治療領域別、2022～2032年
• 放射性医薬品前臨床CRO市場：組織規模別、2022～2032年
• 放射性医薬品前臨床CRO市場：地域別、2022～2032年
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他の中東・アフリカ

第15章 企業プロファイル

• Charles River Laboratories International Inc.
• Pharmaron Beijing Co. Ltd.
• Bioscan Inc.
• Invicro（Konica Minolta）
• PerkinElmer Inc.
• Siemens Healthineers
• IBA Radiopharma Solutions
• Covance Inc.（Labcorp Drug Development）
• NorthStar Medical Radioisotopes LLC
• PAREXEL International Corporation
• Eckert & Ziegler
• Jubilant Radiopharma
• Cardinal Health Inc.
• Curium Pharma
• ImaginAb Inc.
• その他の主要企業

List of Tables

• TABLE 1 Global Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 2 Global Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 3 Global Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 4 Global Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 5 Global Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 6 North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 7 North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 8 North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 9 North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 10 North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 11 U.S. Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 12 U.S. Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 13 U.S. Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 14 U.S. Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 15 U.S. Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 16 Canada Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 17 Canada Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 18 Canada Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 19 Canada Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 20 Canada Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 21 Rest of North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 22 Rest of North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 23 Rest of North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 24 Rest of North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 25 Rest of North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 26 UK and European Union Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 27 UK and European Union Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 28 UK and European Union Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 29 UK and European Union Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 30 UK and European Union Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 31 UK Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 32 UK Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 33 UK Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 34 UK Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 35 UK Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 36 Germany Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 37 Germany Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 38 Germany Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 39 Germany Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 40 Germany Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 41 Spain Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 42 Spain Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 43 Spain Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 44 Spain Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 45 Spain Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 46 Italy Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 47 Italy Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 48 Italy Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 49 Italy Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 50 Italy Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 51 France Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 52 France Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 53 France Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 54 France Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 55 France Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 56 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 57 Rest of Europe Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 58 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 59 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 60 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 61 Asia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 62 Asia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 63 Asia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 64 Asia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 65 Asia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 66 China Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 67 China Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 68 China Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 69 China Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 70 China Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 71 Japan Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 72 Japan Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 73 Japan Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 74 Japan Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 75 Japan Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 76 India Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 77 India Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 78 India Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 79 India Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 80 India Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 81 Australia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 82 Australia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 83 Australia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 84 Australia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 85 Australia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 86 South Korea Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 87 South Korea Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 88 South Korea Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 89 South Korea Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 90 South Korea Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 91 Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 92 Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 93 Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 94 Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 95 Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 96 Brazil Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 97 Brazil Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 98 Brazil Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 99 Brazil Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 100 Brazil Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 101 Mexico Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 102 Mexico Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 103 Mexico Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 104 Mexico Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 105 Mexico Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 106 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 107 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 108 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 109 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 110 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 111 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 112 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 113 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 114 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 115 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 116 GCC Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 117 GCC Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 118 GCC Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 119 GCC Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 120 GCC Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 121 Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 122 Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 123 Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 124 Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 125 Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
• TABLE 126 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
• TABLE 127 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
• TABLE 128 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
• TABLE 129 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
• TABLE 130 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)

List of Figures

• FIG. 1 Global Radiopharmaceutical Preclinical CRO Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Radiopharmaceutical Preclinical CRO Market: Quality Assurance
• FIG. 5 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023
• FIG. 6 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023
• FIG. 7 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023
• FIG. 8 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023
• FIG. 9 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023
• FIG. 10 Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023
• FIG. 11 Market Geographical Opportunity Matrix - Global Radiopharmaceutical Preclinical CRO Market, 2023

FIG. 12Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Players, 2023

FIG. 13Global Radiopharmaceutical Preclinical CRO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2031

• FIG. 14 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 Vs 2032, %
• FIG. 15 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 Vs 2032, %
• FIG. 16 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 Vs 2032, %
• FIG. 17 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 Vs 2032, %
• FIG. 18 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 Vs 2032, %
• FIG. 19 U.S. Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 20 Canada Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 21 Rest of North America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 22 UK Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 23 Germany Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 24 Spain Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 25 Italy Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 26 France Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 27 Rest of Europe Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 28 China Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 29 Japan Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 30 India Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 31 Australia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 32 South Korea Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 33 Rest of Asia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 34 Brazil Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 35 Mexico Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 36 Rest of Latin America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 37 GCC Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 38 Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
• FIG. 39 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032

The radiopharmaceutical preclinical CRO (Contract Research Organization) market is a dynamic sector, integral to advancing preclinical research in the field of radiopharmaceuticals. The radiopharmaceutical preclinical CRO market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, driven by advancements in PET tracers research, the growing demand for oncology and neurology studies, and strategic collaborations among CROs. Challenges in therapeutic radiopharmaceutical development highlight the importance of seamless translational research. The segmentation by radiopharmaceutical type and therapeutic area provides a nuanced understanding of market dynamics, emphasizing the shift towards therapeutic applications and the rising significance of neurology research. The geographic segmentation underscores global trends and the pivotal role of regions like Asia-Pacific in shaping the future of preclinical radiopharmaceutical research.

Advancements in PET Tracers Research

The radiopharmaceutical preclinical CRO market experiences a significant boost from the ongoing advancements in PET (Positron Emission Tomography) tracers research. Evidence suggests that leading CROs, such as Covance and Charles River Laboratories, have actively contributed to the development of novel PET tracers for various preclinical studies. The increased sensitivity and precision offered by PET tracers enable more accurate imaging and analysis in preclinical trials, facilitating a deeper understanding of disease mechanisms and therapeutic responses.

Growing Demand for Oncology Research

The growing demand for oncology research acts as a major driver for the radiopharmaceutical preclinical CRO market. Evidential data indicates that CROs, including Jubilant Biosys and Selcia, have witnessed a surge in preclinical studies focused on oncology. The oncology therapeutic area not only commands substantial revenue in 2024 but also exhibits the highest expected CAGR during the forecast period from 2024 to 2032. This driver underscores the pivotal role of CROs in supporting advancements in cancer research, contributing to the development of innovative radiopharmaceuticals for diagnostic and therapeutic purposes.

Rising Interest in Neurology Studies

The rising interest in neurology studies emerges as another driver for the radiopharmaceutical preclinical CRO market. Evidence-based insights reveal that CROs, such as Pharmaron and WuXi AppTec, are actively engaged in preclinical research focusing on neurology. With advancements in imaging techniques and a growing understanding of neurodegenerative disorders, the neurology therapeutic area exhibits both substantial revenue and a high expected CAGR during the forecast period. This driver highlights the crucial role of CROs in supporting neuroscience research, paving the way for potential breakthroughs in the diagnosis and treatment of neurological conditions.

Challenges in Therapeutic Radiopharmaceutical Development

Despite the positive momentum, challenges in therapeutic radiopharmaceutical development pose a notable restraint. Evidence suggests occasional hurdles in the translation of preclinical findings to clinically viable therapeutic radiopharmaceuticals. CROs, including Eurofins DiscoverX and Nuvisan, actively address these challenges, emphasizing the need for seamless transitions from preclinical to clinical development. This restraint underscores the importance of collaborative efforts and a robust translational research framework to overcome barriers and expedite the clinical translation of preclinically validated radiopharmaceuticals.

Market Analysis by Radiopharmaceutical Type: PET Tracers Dominate the Market

Market segmentation by radiopharmaceutical type reveals dynamic trends in PET tracers, SPECT (Single Photon Emission Computed Tomography) tracers, and therapeutic radiopharmaceuticals. In 2024, PET tracers dominated the market, with the highest revenue and a significant contribution to the overall market share. However, the highest expected CAGR during the forecast period from 2024 to 2032 is in therapeutic radiopharmaceuticals. This segmentation underscores the evolving landscape of radiopharmaceutical preclinical research, with a notable shift toward therapeutic applications.

Market Analysis by Therapeutic Area: Oncology Segment Dominates the Market

The market segmentation by therapeutic area highlights the prominence of oncology, cardiology, neurology, and other areas in preclinical research. In 2024, oncology commands the highest revenue, driven by the increasing focus on cancer-related studies. Simultaneously, neurology emerges with the highest expected CAGR during the forecast period from 2024 to 2032, reflecting a growing emphasis on understanding and addressing neurological disorders. This segmentation provides insights into the diverse applications of radiopharmaceuticals in preclinical studies across multiple therapeutic areas.

North America Remains the Global Leader

The geographic segmentation of the radiopharmaceutical preclinical CRO market unveils global trends and regional variances. In 2024, North America led in terms of both revenue and market share, with CROs like Covance and Charles River Laboratories playing a significant role. However, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, driven by factors such as a growing focus on research and development in emerging economies and increasing collaborations with global pharmaceutical companies. This shift highlights the global nature of the market and the need for region-specific strategies to cater to diverse research landscapes.

Market Competition to Intensify during the Forecast Period

The competitive landscape of the radiopharmaceutical preclinical CRO market is characterized by strategic collaborations and a holistic market outlook. In 2024, CROs such as Covance, Charles River Laboratories, and Pharmaron dominated the market, reflecting their comprehensive capabilities and significant contributions to preclinical research. Strategies encompass collaborative ventures with pharmaceutical companies, expansion of service offerings, and investments in cutting-edge technologies. Looking ahead to the period from 2024 to 2032, these CROs are expected to continue their strategic initiatives, adapting to emerging market dynamics and contributing to the advancement of radiopharmaceutical research on a global scale.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofRadiopharmaceutical Preclinical CRO market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Radiopharmaceutical Preclinical CRO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Service Type

• Safety Assessment

• Bioanalytical Testing

• Dose Formulation

• Regulatory Affairs Support

End-Use Industry

• Pharmaceutical Companies

• Biotechnology Firms

• Academic Research Institutions

• Government Organizations

Radiopharmaceutical Type

• PET Tracers

• SPECT Tracers

• Therapeutic Radiopharmaceuticals

Therapeutic Area

• Oncology

• Cardiology

• Neurology

• Others

Organization Size

• Small and Medium Enterprises (SMEs)

• Large Pharmaceutical Corporations

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Radiopharmaceutical Preclinical CRO market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Radiopharmaceutical Preclinical CRO market?

Which is the largest regional market for Radiopharmaceutical Preclinical CRO market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Radiopharmaceutical Preclinical CRO market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Radiopharmaceutical Preclinical CRO market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Radiopharmaceutical Preclinical CRO Market
• 2.2. Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 (US$ Million)
• 2.3. Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 (US$ Million)
• 2.4. Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 (US$ Million)
• 2.5. Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 (US$ Million)
• 2.6. Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 (US$ Million)
• 2.7. Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023 (US$ Million)
• 2.8. Attractive Investment Proposition by Geography, 2023

3. Radiopharmaceutical Preclinical CRO Market: Competitive Analysis

• 3.1. Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Vendors
• 3.2. Strategies Adopted by Radiopharmaceutical Preclinical CRO Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2023 Versus 2031

4. Radiopharmaceutical Preclinical CRO Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Radiopharmaceutical Preclinical CRO Market Value, 2021 - 2031, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2031
• 5.3. Market Segmentation
  • 5.3.1. Safety Assessment
  • 5.3.2. Bioanalytical Testing
  • 5.3.3. Dose Formulation
  • 5.3.4. Regulatory Affairs Support

6. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2031
• 6.3. Market Segmentation
  • 6.3.1. Pharmaceutical Companies
  • 6.3.2. Biotechnology Firms
  • 6.3.3. Academic Research Institutions
  • 6.3.4. Government Organizations

7. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. Growth & Revenue Analysis: 2023 Versus 2031
• 7.3. Market Segmentation
  • 7.3.1. PET Tracers
  • 7.3.2. SPECT Tracers
  • 7.3.3. Therapeutic Radiopharmaceuticals

8. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. Growth & Revenue Analysis: 2023 Versus 2031
• 8.3. Market Segmentation
  • 8.3.1. Oncology
  • 8.3.2. Cardiology
  • 8.3.3. Neurology
  • 8.3.4. Others

9. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. Growth & Revenue Analysis: 2023 Versus 2031
• 9.3. Market Segmentation
  • 9.3.1. Small and Medium Enterprises (SMEs)
  • 9.3.2. Large Pharmaceutical Corporations

10. North America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
• 10.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
• 10.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
• 10.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
• 10.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
• 10.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
  • 10.7.1.North America
    • 10.7.1.1. U.S.
      • 10.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 10.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 10.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 10.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 10.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 10.7.1.2. Canada
      • 10.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 10.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 10.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 10.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 10.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 10.7.1.3. Rest of North America
      • 10.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 10.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 10.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 10.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 10.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

11. UK and European Union Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
• 11.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
• 11.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
• 11.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
• 11.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
• 11.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
  • 11.7.1.UK and European Union
    • 11.7.1.1. UK
      • 11.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 11.7.1.2. Germany
      • 11.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 11.7.1.3. Spain
      • 11.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 11.7.1.4. Italy
      • 11.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 11.7.1.5. France
      • 11.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 11.7.1.6. Rest of Europe
      • 11.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 11.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 11.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 11.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 11.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

12. Asia Pacific Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

• 12.1. Market Overview
• 12.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
• 12.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
• 12.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
• 12.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
• 12.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
• 12.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
  • 12.7.1.Asia Pacific
    • 12.7.1.1. China
      • 12.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 12.7.1.2. Japan
      • 12.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 12.7.1.3. India
      • 12.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 12.7.1.4. Australia
      • 12.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 12.7.1.5. South Korea
      • 12.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 12.7.1.6. Rest of Asia Pacific
      • 12.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 12.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 12.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 12.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 12.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

13. Latin America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

• 13.1. Market Overview
• 13.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
• 13.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
• 13.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
• 13.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
• 13.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
• 13.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
  • 13.7.1.Latin America
    • 13.7.1.1. Brazil
      • 13.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 13.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 13.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 13.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 13.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 13.7.1.2. Mexico
      • 13.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 13.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 13.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 13.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 13.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 13.7.1.3. Rest of Latin America
      • 13.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 13.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 13.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 13.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 13.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

14. Middle East and Africa Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

• 14.1. Market Overview
• 14.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
• 14.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
• 14.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
• 14.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
• 14.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
• 14.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
  • 14.7.1.Middle East and Africa
    • 14.7.1.1. GCC
      • 14.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 14.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 14.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 14.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 14.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 14.7.1.2. Africa
      • 14.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 14.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 14.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 14.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 14.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
    • 14.7.1.3. Rest of Middle East and Africa
      • 14.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
      • 14.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
      • 14.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
      • 14.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
      • 14.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

15. Company Profile

• 15.1. Charles River Laboratories International, Inc.
  • 15.1.1. Company Overview
  • 15.1.2. Financial Performance
  • 15.1.3. Product Portfolio
  • 15.1.4. Strategic Initiatives
• 15.2. Pharmaron Beijing Co., Ltd.
  • 15.2.1. Company Overview
  • 15.2.2. Financial Performance
  • 15.2.3. Product Portfolio
  • 15.2.4. Strategic Initiatives
• 15.3. Bioscan, Inc.
  • 15.3.1. Company Overview
  • 15.3.2. Financial Performance
  • 15.3.3. Product Portfolio
  • 15.3.4. Strategic Initiatives
• 15.4. Invicro (Konica Minolta)
  • 15.4.1. Company Overview
  • 15.4.2. Financial Performance
  • 15.4.3. Product Portfolio
  • 15.4.4. Strategic Initiatives
• 15.5. PerkinElmer, Inc.
  • 15.5.1. Company Overview
  • 15.5.2. Financial Performance
  • 15.5.3. Product Portfolio
  • 15.5.4. Strategic Initiatives
• 15.6. Siemens Healthineers
  • 15.6.1. Company Overview
  • 15.6.2. Financial Performance
  • 15.6.3. Product Portfolio
  • 15.6.4. Strategic Initiatives
• 15.7. IBA Radiopharma Solutions
  • 15.7.1. Company Overview
  • 15.7.2. Financial Performance
  • 15.7.3. Product Portfolio
  • 15.7.4. Strategic Initiatives
• 15.8. Covance, Inc. (Labcorp Drug Development)
  • 15.8.1. Company Overview
  • 15.8.2. Financial Performance
  • 15.8.3. Product Portfolio
  • 15.8.4. Strategic Initiatives
• 15.9. NorthStar Medical Radioisotopes, LLC
  • 15.9.1. Company Overview
  • 15.9.2. Financial Performance
  • 15.9.3. Product Portfolio
  • 15.9.4. Strategic Initiatives
• 15.10. PAREXEL International Corporation
  • 15.10.1. Company Overview
  • 15.10.2. Financial Performance
  • 15.10.3. Product Portfolio
  • 15.10.4. Strategic Initiatives
• 15.11. Eckert & Ziegler
  • 15.11.1. Company Overview
  • 15.11.2. Financial Performance
  • 15.11.3. Product Portfolio
  • 15.11.4. Strategic Initiatives
• 15.12. Jubilant Radiopharma
  • 15.12.1. Company Overview
  • 15.12.2. Financial Performance
  • 15.12.3. Product Portfolio
  • 15.12.4. Strategic Initiatives
• 15.13. Cardinal Health, Inc.
  • 15.13.1. Company Overview
  • 15.13.2. Financial Performance
  • 15.13.3. Product Portfolio
  • 15.13.4. Strategic Initiatives
• 15.14. Curium Pharma
  • 15.14.1. Company Overview
  • 15.14.2. Financial Performance
  • 15.14.3. Product Portfolio
  • 15.14.4. Strategic Initiatives
• 15.15. ImaginAb, Inc.
  • 15.15.1. Company Overview
  • 15.15.2. Financial Performance
  • 15.15.3. Product Portfolio
  • 15.15.4. Strategic Initiatives
• 15.16. Other Notable Players
  • 15.16.1. Company Overview
  • 15.16.2. Financial Performance
  • 15.16.3. Product Portfolio
  • 15.16.4. Strategic Initiatives